These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 37167362)
1. Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations. Wang RS; Loscalzo J Circ Res; 2023 May; 132(10):1374-1386. PubMed ID: 37167362 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 and its long-term impact on the cardiovascular system. Philip B; Mukherjee P; Khare Y; Ramesh P; Zaidi S; Sabry H; Harky A Expert Rev Cardiovasc Ther; 2023 Mar; 21(3):211-218. PubMed ID: 36856339 [TBL] [Abstract][Full Text] [Related]
3. Cardiac Involvement of COVID-19: A Comprehensive Review. Chang WT; Toh HS; Liao CT; Yu WL Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. Talasaz AH; Kakavand H; Van Tassell B; Aghakouchakzadeh M; Sadeghipour P; Dunn S; Geraiely B Cardiovasc Drugs Ther; 2021 Apr; 35(2):249-259. PubMed ID: 32671601 [TBL] [Abstract][Full Text] [Related]
5. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670 [No Abstract] [Full Text] [Related]
6. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication. Abdel Moneim A; Radwan MA; Yousef AI Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Luo J; Zhu X; Jian J; Chen X; Yin K Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706 [TBL] [Abstract][Full Text] [Related]
8. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight. Akilesh SM; J R; Palanisamy D; Wadhwani A Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651 [TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Soumya RS; Unni TG; Raghu KG Cardiovasc Drugs Ther; 2021 Jun; 35(3):411-425. PubMed ID: 32926272 [TBL] [Abstract][Full Text] [Related]
10. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. Ting CT; Chen BS Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008 [TBL] [Abstract][Full Text] [Related]
12. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Li N; Zhu L; Sun L; Shao G Stem Cell Res; 2021 Mar; 51():102168. PubMed ID: 33485182 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities. Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761 [TBL] [Abstract][Full Text] [Related]
14. The Cardiac Effects of COVID-19: Review of articles. Niazi S; Niazi F; Doroodgar F; Safi M Curr Probl Cardiol; 2022 Feb; 47(2):100981. PubMed ID: 34534589 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. Shah KS; Hale Hammond ME; Drakos SG; Anderson JL; Fang JC; Knowlton KU; Shaw RM Future Cardiol; 2021 Oct; 17(7):1277-1291. PubMed ID: 33739142 [TBL] [Abstract][Full Text] [Related]
16. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Liu D; Zeng X; Ding Z; Lv F; Mehta JL; Wang X Front Pharmacol; 2021; 12():699949. PubMed ID: 34512335 [TBL] [Abstract][Full Text] [Related]